Clearwater Capital sells 3.58% stake in Lyka Labs

11 Sep 2014 Evaluate

Clearwater Capital Partners Cyprus has sold 7,71,750 shares or 3.58% stake of Lyka Labs in the open market. With this, the consolidated shareholding of Clearwater Cyprus and Clearwater Singapore (Fund III) has reduced from 11.94% to 8.36%.

As on June 30, 2014, the promoters holding in the company stood at 23.30%, while institutions and non-institutions held 4.93% and 71.78% stake in the company, respectively.

Lyka Labs is engaged in the manufacture of pharmaceutical products. It also manufactures Veterinary products including injections, powders, creams and suspensions. The company offers various surgical disposables, such as syringes, surgical blades, cotton crepe bandage and first aid kits.

Lyka Labs Share Price

78.32 -2.72 (-3.36%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×